Association of donor hepatectomy time with liver transplantation outcomes: A multicenter retrospective study

Table 1 Baseline characteristics of the donors, recipients, and surgical procedures, n (%)

Donor characteristics	Values
Demographics
Age (yr)	41 ± 14
Men	150 (62)
BMI (kg/m2)	25.5 ± 3.5
Cause of death
Stroke	118 (48.6)
Traumatic brain injury	96 (39.5)
Anoxic encephalopathy	19 (7.8)
Others	10 (4.1)
Organ Procurement
Regional	215 (88.5)
Local	28 (11.5)
Disease severity
Time on MV before donation (d)	4 (3-7)
Presence of sepsis	125 (51.4)
Need for vasopressors	201 (82.7)
Cardiac arrest	48 (19.8)
Biochemical measurements
ALT (U/L)	29 (19-62)
AST (U/L)	40 (24-70)
Bilirubin (mg/dL)	0.5 (0.3-0.8)
Creatinine (mg/dL)	1 (0.7-1.4)
Sodium (mEq/L)	148 ± 10
Platelets (10³/mm³)	158 (106-212)
Blood glucose (mg/dL)	243 ± 91
Recipients’ characteristics	Values
Demographics
Age (yr)	56 ± 11
Men	175 (72)
BMI (kg/m2)	27.8 ± 4.8
Blood group
O	89 (36.6)
A	108 (44.5)
B	34 (14)
AB	11 (4.5)
Indications for liver transplantation
Viral hepatitis	78 (32)
Alcoholic liver disease	63 (26)
Non-alcoholic steatohepatitis	29 (12)
Cryptogenic	23 (9.5)
Others	50 (20.5)
Disease severity
MELD score	20 ± 8
Presence of HCC	92 (38)
Previous abdominal surgery	88 (36.2)
Previous decompensation	153 (63)
Biochemical measurements
ALT (U/L)	611 (375-1041)
AST (U/L)	1055 (580-1829)
Bilirubin (mg/dL)	4 (2.3-6.2)
Creatinine (mg/dL)	0.9 (0.7-1.2)
Platelets (10³/mm³)	105 (67-142)
INR	2.1 (1.7-2.7)
Albumin (g/dL)	2.6 (2.3-2.9)
Surgical procedures
Cold ischemia time (min)	405 (329-492)
Warm ischemia time (min)	34 (30-37)
Donor hepatectomy time (min)	29 (23-40)
Need for thrombectomy	33 (13.6)
Need for arterial reconstruction	31 (12.8)

BMI: Body mass index; ALT: Alanine aminotransferase; AST: Aspartate aminotransferase; MELD: Model of end-stage liver disease; MV: Mechanical ventilation; HCC: Hepatocellular carcinoma; INR: International normalized ratio. Values are mean ± SD or median and interquartile range.